REgistry of MisOprostol 200 µg Vaginal dElivery System
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The design of the study is post-marketing, observational, multi-centre and open-label. The
study does not provide treatment; only patients to whom misoprostol 200 µg vaginal delivery
system (VDS) is prescribed may be included. All directions for medication usage and patient
monitoring are solely at the discretion of the investigator in accordance with their usual
practice and must be consistent with the Dutch prescribing information of misoprostol 200 µg
VDS. No other (invasive) study-related interventions or measurements are done, other than the
procedures routinely performed during induction of labour. No effort is expected from the
study subjects. 150 patients from 20 Dutch centres will be included.